Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial

This publication has 21 references indexed in Scilit:

• Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
  Journal of Clinical Oncology, 2009
• Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
  Molecular Cancer Therapeutics, 2008
• Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
  Journal of Clinical Oncology, 2008
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
  New England Journal of Medicine, 2007
• Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
  The Lancet, 2007
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
  Science, 2005
• The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression
  Urologic Oncology: Seminars and Original Investigations, 2004
• A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
  New England Journal of Medicine, 2003
• Tumour angiogenesis: pathophysiology and clinical significance
  The Netherlands Journal of Medicine, 1996